
Chetan Bettegowda MD
Assistant Professor of Neurological Surgery, Assistant Professor of Oncology, Johns Hopkins University School of Medicine
Join to View Full Profile
10753 Falls RoadPavilion II, Suite 115Lutherville, MD 21093
Phone+1 410-955-6406
Fax+1 410-616-7231
Dr. Bettegowda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Johns Hopkins UniversityResidency, Neurological Surgery, 2006 - 2012
- Johns Hopkins University School of MedicineInternship, Transitional Year, 2005 - 2006
- Johns Hopkins University School of MedicineClass of 2005
Certifications & Licensure
- MD State Medical License 2012 - 2026
- NC State Medical License 2020 - 2022
- American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Clinical Trials
- Primary Tumor Research and Outcomes Network Start of enrollment: 2016 Oct 01
Roles: Contact
Publications & Presentations
PubMed
- Prevalence, therapeutic approaches, and survival rates of brain metastases in non-small cell lung cancer: a multi-institutional claims-based study from 2014 to 2024.Megan Parker, Kelly Jiang, Anita Kalluri, Alyssa G Arbuiso, Austin Carmichael
Journal of Neuro-Oncology. 2025-10-01 - Incidence, demographics, and survival of patients with brain metastases from stage IV colorectal cancer: a population-based study from 2013 to 2023.Melanie Alfonzo Horowitz, Marvin Li, Megan Parker, Alyssa Arbuiso, Ryan Gensler
Journal of Neuro-Oncology. 2025-10-01 - Preoperative assessment of tumor eloquence and resectability: an international survey.Emma Rammeloo, Jacob S Young, Joost W Schouten, Eelke M Bos, Shawn L Hervey-Jumper
Journal of Neuro-Oncology. 2025-10-01
Journal Articles
- Subependymal Giant Cell Astrocytoma-like Astrocytoma: A Neoplasm with a Distinct Phenotype and Frequent Neurofibromatosis Type-1-AssociationMurat Gokden, Fausto J Rodriguez, Mark Jentoft, Chetan Bettegowda, Caterina Giannini, Aditya Raghunathan, Doris Lin, Nature
Authored Content
- The Radiographic Effects of Surgical Approach and Use of Retractors on the Brain After Anterior Cranial Fossa Meningioma ResectionJanuary 2018
- The Radiographic Effects of Surgical Approach and Use of Retractors on the Brain After Anterior Cranial Fossa Meningioma ResectionJanuary 2018
Press Mentions
- New Test Accurately Detects Brain Cancer in Cerebrospinal FluidAugust 27th, 2025
- Test Detects Brain Cancers in Cerebrospinal Fluid with High AccuracyAugust 27th, 2025
- Combining Laboratory Techniques Yields Wealth of Information About Deadly Brain TumorsMay 14th, 2025
- Join now to see all
Grant Support
- Integrating circulating tumor DNA assay and protein-based MRI to accurately monitor glioma therapyJOHNS HOPKINS UNIVERSITY2023–2028
- Integrating circulating tumor DNA assay and protein-based MRI to accurately monitor glioma therapyJOHNS HOPKINS UNIVERSITY2023–2028
- Integrating circulating tumor DNA assay and protein-based MRI to accurately monitor glioma therapyJOHNS HOPKINS UNIVERSITY2023–2028
- Multi-analyte Approach for Earlier Detection of Cancers in Non Plasma BiofluidsJOHNS HOPKINS UNIVERSITY2018–2028
- Multi-analyte Approach for Earlier Detection of Cancers in Non Plasma BiofluidsJOHNS HOPKINS UNIVERSITY2018–2028
- Multi-analyte Approach for Earlier Detection of Cancers in Non Plasma BiofluidsJOHNS HOPKINS UNIVERSITY2018–2028
- Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablationCASE WESTERN RESERVE UNIVERSITY2022–2027
- Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablationCASE WESTERN RESERVE UNIVERSITY2022–2027
- Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablationCASE WESTERN RESERVE UNIVERSITY2022–2027
- Cell-free DNA-Based Analysis for Diagnosis, Monitoring and Optimization of Therapy for Patients with Primary Central Nervous System LymphomasJOHNS HOPKINS UNIVERSITY2022–2025
- Phase IIA Trial of Dichloroacetate for Glioblastoma Multiforme, IND137007, 09172019UNIVERSITY OF FLORIDA2021–2025
- Phase IIA Trial of Dichloroacetate for Glioblastoma Multiforme, IND137007, 09172019UNIVERSITY OF FLORIDA2021–2025
- Phase IIA Trial of Dichloroacetate for Glioblastoma Multiforme, IND137007, 09172019UNIVERSITY OF FLORIDA2021–2025
- Interrogating malignant gliomas using released tumor DNA in cerebrospinal fluidJOHNS HOPKINS UNIVERSITY2018–2025
- Interrogating malignant gliomas using released tumor DNA in cerebrospinal fluidJOHNS HOPKINS UNIVERSITY2018–2025
- Interrogating malignant gliomas using released tumor DNA in cerebrospinal fluidJOHNS HOPKINS UNIVERSITY2018–2025
- Multi-omic CSF Assay for the Diagnosis of Brain CancersBELAY DIAGNOSTICS, LLC2024
Professional Memberships
- Member
Other Languages
- Kannada
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/chetan-bettegowda
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: